Intrinsic Value of S&P & Nasdaq Contact Us

Kalaris Therapeutics Inc KLRS

NASDAQ Global Market

SharesGrow Score
52/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.00
+257.8%

Kalaris Therapeutics Inc (KLRS) current share price is $5.87. The gold spot price is $4,825.20 per troy ounce. Using the formula: KLRS in gold = $5.87 × 31.1035 ÷ $4,825.20 = 0.0378 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of KLRS when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding KLRS shares over the measured period.

KLRS in US Dollars
Gold in US Dollars
KLRS in Gold (grams per share)

Real Wealth Growth Rate

KLRS
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{KLRS}_{\text{gold}}(t) = \frac{P_{\text{KLRS}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{KLRS}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{KLRS}_{\text{gold}}^{(T)}}{\text{KLRS}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{KLRS}_\text{gold}^{(0)}$ = initial gold-price, $\text{KLRS}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

OVID
OVID
Ovid Therapeutics Inc.
$2.76
-6.76%
STTK
STTK
Shattuck Labs, Inc.
$7.17
+5.75%
STRO
STRO
Sutro Biopharma, Inc.
$29.77
+3.44%
CNTX
CNTX
Context Therapeutics Inc.
$2.51
-0.60%
ARTV
ARTV
Artiva Biotherapeutics, Inc.
$9.10
+21.50%
CNTB
CNTB
Connect Biopharma Holdings Limited
$2.93
-3.93%
IFRX
IFRX
InflaRx N.V.
$1.21
+6.14%
IMA
IMA
ImageneBio Inc
$5.65
-1.40%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message